New Zealand markets closed

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
106.01+1.60 (+1.53%)
At close: 4:00PM EDT
106.01 0.00 (0.00%)
After hours: 07:17PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close104.41
Bid104.63 x 1000
Ask107.00 x 800
Day's range105.39 - 106.09
52-week range63.22 - 107.24
Avg. volume1,024,162
Market cap242.574B
Beta (5Y monthly)0.28
PE ratio (TTM)35.48
EPS (TTM)2.99
Earnings dateN/A
Forward dividend & yield1.47 (1.39%)
Ex-dividend date16 Aug 2021
1y target est116.28
  • Motley Fool

    If I Could Only Own 1 Healthcare Stock, This Is What It Would Be

    It's not that difficult to spread your investments out across many companies and hope for the best over a long time horizon. Another took a different route by making a bet on ARK Genomic Revolution ETF (NYSEMKT: ARKG) in the hope of owning the first healthcare industry trillion-dollar market cap company. Jason Hawthorne (Novo Nordisk): Novo Nordisk is one of three large drug manufacturers that account for the majority of insulin production in the world.

  • GlobeNewswire

    Novo Nordisk A/S – Share repurchase programme

    Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 18 October 2021 – On 4 August 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 18 billion to be executed during a 12-month period be

  • Zacks

    GSK or NVO: Which Is the Better Value Stock Right Now?

    GSK vs. NVO: Which Stock Is the Better Value Option?